Slayer Angel
An obscure modern hybrid with limited documentation, often confused with similarly named strains and marketed on vibes rather than verified genetics.
Slayer Angel is one of those strains that shows up in seedbank listings and dispensary menus with confident lineage claims, but the documentation behind it is thin. There is no peer-reviewed chemistry, no breeder paper trail you can independently verify, and the effect descriptions you'll read are essentially marketing copy. Treat anything specific you hear about its THC percentage, terpene profile, or parentage as a claim, not a fact. If you find it on a shelf, judge it by the lab sticker, not the name.
Overview
Slayer Angel is a cannabis cultivar name that appears intermittently in online seed listings and dispensary menus, but it lacks the kind of paper trail that better-known strains have. There is no entry in peer-reviewed chemotype surveys No data, no widely cited breeder release notes, and no verified lab data we could locate at the time of writing.
What you are most likely to encounter is a name attached to flower from a small grower, with effect and flavor descriptions written by the retailer rather than the breeder. That doesn't mean the plant isn't real — small-batch cultivars exist all the time — it just means almost everything specific said about it should be treated as a claim, not a fact.
Chemistry: cannabinoids and terpenes
We have no reliable cannabinoid or terpene data for Slayer Angel No data. Public chemotype databases like those summarized in peer-reviewed surveys of commercial cannabis [1] do not include it, and we found no published certificate of analysis (COA) tied to a verifiable batch.
If you buy flower sold under this name, the only meaningful chemistry information is the COA on that specific batch. Cannabinoid content in commercial flower is heavily influenced by grower, harvest timing, and curing — research has shown substantial chemical variation between batches sold under the same strain name [2][3]. In other words: two jars labeled 'Slayer Angel' from different growers can have meaningfully different THC totals and terpene profiles.
Terpene-based effect predictions (e.g., 'myrcene above 0.5% makes it sedating') are popular folklore but not established science Disputed. Don't let a strain name or a terpene marketing chart substitute for actually reading the lab results.
Reported effects
There is no clinical research on Slayer Angel specifically No data. As with virtually every named strain, effect claims come from user reports on consumer review sites and dispensary copy, not controlled studies.
The broader scientific picture is that strain name is a poor predictor of subjective effects. A widely cited analysis of commercial cannabis found that 'indica' and 'sativa' labels don't reliably map onto chemical profiles [1], and a separate study reported that the same strain name from different sources often differs substantially in chemistry [2]. Acute effects of cannabis are driven mostly by THC dose, route of administration, tolerance, and setting — not by branding [4].
If you're trying a flower called Slayer Angel, expect what you'd expect from any THC-dominant hybrid at the dose you take, and pay more attention to the COA than the name.
Lineage (disputed / unverified)
Claimed parentages for Slayer Angel circulate on consumer strain-database sites, but we could not find a primary breeder source confirming any specific lineage Disputed. Consumer-edited strain databases are known to contain unverified and sometimes contradictory parentage entries [5].
Unless and until a named breeder publishes release notes — ideally with photos, dates, and seed batch identifiers — treat any 'X crossed with Y' claim for this strain as unconfirmed. This is the norm for obscure cultivars, not an unusual situation.
Cultivation basics
We have no verified cultivation data for Slayer Angel No data: no documented flowering time range, no published yield numbers, no notes on nutrient sensitivity or pest resistance from a credible breeder source.
Generic guidance for an unknown modern photoperiod hybrid: expect roughly 8–10 weeks of flowering indoors, standard indoor environmental targets (around 20–26 °C, 40–60% RH dropping in late flower), and the usual integrated pest management. None of that is strain-specific to Slayer Angel — it's just baseline cannabis horticulture [6]. If you grow it, your own notes will be more useful than anything currently published under this name.
Marketing vs. reality
A few specific things worth flagging:
- The name does work. 'Slayer Angel' sounds evocative, and edgy strain names sell. That is the main thing the name reliably does.
- Effect descriptions are usually copy, not data. Phrases like 'cerebral uplift followed by full-body relaxation' are template language applied to many strains; they are not measurements Anecdote.
- Lineage claims are not certifications. Without genetic testing or a verifiable breeder record, two plants sold as the same strain can be unrelated [2][5].
- Indica/sativa labeling is not predictive. This applies to Slayer Angel as it does to every other strain [1] Strong evidence.
If the flower is good, it's good. Just don't pay a premium for a story the seller can't back up.
Sources
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The cannabinoid content of legal cannabis in Washington State varies systematically across testing facilities and popular consumer products. Scientific Reports, 8, 4519.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.